G-quadruplex nucleic acids as therapeutic targets - PubMed (original) (raw)
G-quadruplex nucleic acids as therapeutic targets
Shankar Balasubramanian et al. Curr Opin Chem Biol. 2009 Jun.
Abstract
Nucleic acid sequences containing several short runs of guanine nucleotides can form complex higher order structures, termed quadruplexes. Their occurrence has been most extensively characterised at the telomeric ends of eukaryotic chromosomes, whose DNA comprises such sequences, and where the extreme 3' ends are single-stranded. This enables relatively facile formation of quadruplex arrangements under the influence of a quadruplex-selective small molecule to compete effectively with telomeric protein-DNA interactions. Occurrences of quadruplexes within the human and other genomes have been mapped by bioinformatics surveys, which have revealed over-representations in promoter regions, especially of genes involved in replication, such as oncogenes, as well as in 5'UTR regions. The highly distinctive nature of quadruplex topologies suggests that they can act as novel therapeutic targets, for example in the selective inhibition of transcription of a given oncogene, using designed small molecules to stabilise a particular quadruplex. This offers the prospect of an alternative to, for example, direct kinase targeting with small molecules, without the attendant issues of active-site resistance. We survey here the basis of these approaches, together with current progress, and discuss the mechanistic issues posed by quadruplex targeting.
Figures
Figure 1
Structures of three quadruplex-forming ligands for which in vivo data have been reported.
figure 2
Schematic of the cellular consequences of inducing quadruplex formation by means of a small-molecule ligand within the single-stranded telomeric DNA overhang at the 3′ end of a cancer cell chromosome. The single-strand binding protein hPOT1 is displaced from the overhang by quadruplex formation, so that recognition of the overhang by the RNA subunit of telomerase (hTR) action is impaired, telomerase-catalysed synthesis of telomeric DNA repeats is inhibited and telomeric DNA is shortened. The unmasking of the overhang from associated proteins can also lead to a DNA damage response.
Figure 3
Schematic of the promoter-G-quadruplex hypothesis. G-quadruplex-forming sequence motifs in the upstream (promoter) region (in green) of genes (in red) may fold into G-quadruplex structures. The formation of G-quadruplex, rather than duplex, DNA structure in the promoter is associated with an altered state of transcription. This hypothesis would suggest that any molecule capable of interacting with the specific G-quadruplex could modulate the transcriptional activity of the associated gene.
Similar articles
- DNA G-Quadruplex in Human Telomeres and Oncogene Promoters: Structures, Functions, and Small Molecule Targeting.
Chen L, Dickerhoff J, Sakai S, Yang D. Chen L, et al. Acc Chem Res. 2022 Sep 20;55(18):2628-2646. doi: 10.1021/acs.accounts.2c00337. Epub 2022 Sep 2. Acc Chem Res. 2022. PMID: 36054116 Free PMC article. - Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer.
Neidle S. Neidle S. FEBS J. 2010 Mar;277(5):1118-25. doi: 10.1111/j.1742-4658.2009.07463.x. Epub 2009 Nov 27. FEBS J. 2010. PMID: 19951354 Review. - Small-molecule G-quadruplex interactions: Systematic exploration of conformational space using multiple molecular dynamics.
Husby J, Todd AK, Platts JA, Neidle S. Husby J, et al. Biopolymers. 2013 Dec;99(12):989-1005. doi: 10.1002/bip.22340. Biopolymers. 2013. PMID: 23828641 - Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics.
Patel DJ, Phan AT, Kuryavyi V. Patel DJ, et al. Nucleic Acids Res. 2007;35(22):7429-55. doi: 10.1093/nar/gkm711. Epub 2007 Oct 2. Nucleic Acids Res. 2007. PMID: 17913750 Free PMC article. Review. - G-quadruplexes as therapeutic targets.
Neidle S, Read MA. Neidle S, et al. Biopolymers. 2000-2001;56(3):195-208. doi: 10.1002/1097-0282(2000)56:3<195::AID-BIP10009>3.0.CO;2-5. Biopolymers. 2000. PMID: 11745111 Review.
Cited by
- Benzimidazole-based small molecules as anticancer agents targeting telomeric G-quadruplex and inhibiting telomerase enzyme.
Elango H, Das RN, Saha A. Elango H, et al. Future Med Chem. 2024;16(19):2043-2067. doi: 10.1080/17568919.2024.2400982. Epub 2024 Sep 24. Future Med Chem. 2024. PMID: 39316718 Review. - Stabilization of G-Quadruplex Structures of the SARS-CoV-2 Genome by TMPyP4, BRACO19, and PhenDC3.
Cervenak M, Molnár OR, Horváth P, Smeller L. Cervenak M, et al. Int J Mol Sci. 2024 Feb 20;25(5):2482. doi: 10.3390/ijms25052482. Int J Mol Sci. 2024. PMID: 38473730 Free PMC article. - G-quadruplexes in MTOR and induction of autophagy.
Majumder P, Shukla C, Arya A, Sharma S, Datta B. Majumder P, et al. Sci Rep. 2024 Jan 30;14(1):2525. doi: 10.1038/s41598-024-52561-y. Sci Rep. 2024. PMID: 38291093 Free PMC article. - G-Quadruplexes in the Regulation of Viral Gene Expressions and Their Impacts on Controlling Infection.
Zareie AR, Dabral P, Verma SC. Zareie AR, et al. Pathogens. 2024 Jan 8;13(1):60. doi: 10.3390/pathogens13010060. Pathogens. 2024. PMID: 38251367 Free PMC article. Review.
References
- Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood. 2009;112:4808–4817. - PubMed
- Hambley TW. Is anticancer drug development heading in the right direction? Cancer Res. 2009;69:1259–1262. - PubMed
- Davis JT. G-quartets 40 years later: from 5′-GMP to molecular biology and supramolecular chemistry. Angew Chem Int Ed. 2004;43:668–698. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources